ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Sep 16, 2010
ELITE PHARMACEUTICALS ANNOUNCES LICENSE, MANUFACTURING AND SUPPLY AGREEMENTS FOR FOUR GENERIC PRODUCTS
Sep 01, 2010
ELITE PHARMACEUTICALS ANNOUNCES ACQUISITION OF GENERIC NALTREXONE PRODUCT
Aug 17, 2010
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal 2011
Aug 10, 2010
Elite Pharmaceuticals, Inc. to Discuss First Quarter Results of Operations on Tuesday, August 17, 2010
Jul 02, 2010
Elite Pharmaceuticals, Inc. Announces 2010 Fourth Quarter and Year-End Investor Conference Call on Thursday, July 8, 2010
Jun 30, 2010
ELITE ANNOUNCES SETTLEMENT OF LITIGATION
May 24, 2010
ELITE PHARMACEUTICALS ANNOUNCES ACQUISITION OF GENERIC HYDROMORPHONE PRODUCT
Feb 22, 2010
Elite Pharmaceuticals, Inc. 3rd Quarter 2010 Financial Results
Feb 16, 2010
Elite Pharmaceuticals, Inc. To Host Quarterly Conference Call on Friday, February 19, 2010
Dec 02, 2009
ELITE PHRAMACEUTALS AND THEPHARMANETWORK ANNOUNCE FDA APPROVAL FOR GENERIC METHADONE TABLETS
14
15
16
17
18
19
20
21
22
23
24
<<
<
>
>>
Back to top
Privacy
